Cargando…
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
Monoclonal antibodies or fusion proteins, defined as biological drugs, have modified the natural history of numerous immune-mediated disorders, allowing the development of therapies aimed at blocking the pathophysiological pathways of the disease, providing greater efficacy and safety than conventio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculdade de Medicina / USP
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449932/ https://www.ncbi.nlm.nih.gov/pubmed/34614113 http://dx.doi.org/10.6061/clinics/2021/e3015 |